The coxib conundrum: lessons from the rise and fall of rofecoxib. [electronic resource]
Producer: 20050317Description: 417-21 p. digitalISSN:- 1075-2765
- Animals
- Blood Pressure -- drug effects
- Cardiovascular Diseases -- chemically induced
- Cohort Studies
- Cyclooxygenase Inhibitors -- adverse effects
- Drug Industry -- ethics
- Drug and Narcotic Control
- Humans
- Lactones -- adverse effects
- Peptic Ulcer -- chemically induced
- Product Surveillance, Postmarketing
- Randomized Controlled Trials as Topic
- Sulfones -- adverse effects
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.